Review of Genetics in Age Related Macular Degeneration

REFERENCES

• Bird A C, Bressler N M, Bressler S B, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367–74
   PubMed Web of Science ®Google Scholar
• Hamdi H K, Kenney C. Age-related macular degeneration: a new viewpoint. Front Biosci 2003; 8: e305–14
   Web of Science ®Google Scholar
• Seddon J M, Sharma S, Adelman R A. Evaluation of the clinical age-related maculopathy staging system. Ophthalmology 2006; 113: 260–6
   PubMed Web of Science ®Google Scholar
• Friedman D S, O'Colmain B J, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122: 564–72
   PubMed Web of Science ®Google Scholar
• Klein R, Klein B E, Cruickshanks K J. The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 1999; 18: 371–89
   PubMed Web of Science ®Google Scholar
• Klein R, Peto T, Bird A, Vannewkirk M R. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004; 137: 486–95
   PubMed Web of Science ®Google Scholar
• Schachat A P, Hyman L, Leske M C, Connell A M, Wu S Y. Features of age-related macular degeneration in a black population. The Barbados Eye Study Group. Arch Ophthalmol 1995; 113: 728–35
   PubMedGoogle Scholar
• Friedman D S, Katz J, Bressler N M, Rahmani B, Tielsch J M. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology 1999; 106: 1049–55
   PubMed Web of Science ®Google Scholar
• Frank R N, Puklin J E, Stock C, Canter L A. Race, iris color, and age-related macular degeneration. Trans Am Ophthalmol Soc 2000; 98: 109–15, discussion 115–7
   PubMedGoogle Scholar
• Moeller S M, Mares J A. Ethnic differences in diet and age-related maculopathies. Int Ophthalmol Clin 2003; 43: 47–59
   PubMedGoogle Scholar
• Capone A, Jr., Wallace R T, Meredith T A. Symptomatic choroidal neovascularization in blacks. Arch Ophthalmol 1994; 112: 1091–7
   Google Scholar
• Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 2001; 108: 697–704
   PubMed Web of Science ®Google Scholar
• Vingerling J R, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995; 102: 205–10
   PubMed Web of Science ®Google Scholar
• Wu L H. Study of aging macular degeneration in China. Jpn J Ophthalmol 1987; 31: 349–67
   PubMedGoogle Scholar
• Jonasson F, Arnarsson A, Sasaki H, Peto T, Sasaki K, Bird A C. The prevalence of age-related maculopathy in iceland: Reykjavik eye study. Arch Ophthalmol 2003; 121: 379–85
   PubMedGoogle Scholar
• Jonasson F, Arnarsson A, Peto T, Sasaki H, Sasaki K, Bird A C. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. Ophthalmology 2005; 112: 132–8
   Google Scholar
• Bjornsson O M, Syrdalen P, Bird A C, Peto T, Kinge B. The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: the Oslo Macular Study. Acta Ophthalmol Scand 2006; 84: 636–41
   Google Scholar
• Cruickshanks K J, Hamman R F, Klein R, Nondahl D M, Shetterly S M. The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy. Arch Ophthalmol 1997; 115: 242–50
   PubMed Web of Science ®Google Scholar
• Klein R, Klein B E, Tomany S C, Meuer S M, Huang G H. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 2002; 109: 1767–79
   PubMed Web of Science ®Google Scholar
• van Leeuwen R, Klaver C C, Vingerling J R, Hofman A, de Jong P T. Epidemiology of age-related maculopathy: a review. Eur J Epidemiol 2003; 18: 845–54
   PubMed Web of Science ®Google Scholar
• Mitchell P, Smith W, Attebo K, Wang J J. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995; 102: 1450–60
   PubMed Web of Science ®Google Scholar
• VanNewkirk M R, Nanjan M B, Wang J J, Mitchell P, Taylor H R, McCarty C A. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 2000; 107: 1593–600
   PubMed Web of Science ®Google Scholar
• Seddon J M, Willett W C, Speizer F E, Hankinson S E. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996; 276: 1141–6
   PubMed Web of Science ®Google Scholar
• Evans J R, Fletcher A E, Wormald R P. 28,000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol 2005; 89: 550–3
   PubMed Web of Science ®Google Scholar
• Clemons T E, Milton R C, Klein R, Seddon J M, Ferris F L. 3rd. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 2005; 112: 533–9
   PubMed Web of Science ®Google Scholar
• Thornton J, Edwards R, Mitchell P, Harrison R A, Buchan I, Kelly S P. Smoking and age-related macular degeneration: a review of association. Eye 2005; 19: 935–44
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Kiyohara Y, Yoshida A, Iida M, Nose Y, Ishibashi T. The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci 2005; 46: 1907–10
   PubMed Web of Science ®Google Scholar
• De Black S S. Cigarette smoking as a risk factor for cataract and age-related macular degeneration: a review of the literature. Optometry 2003; 74: 99–110
   Google Scholar
• Fraser-Bell S, Wu J, Klein R, Azen S P, Varma R. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study. Am J Ophthalmol 2006; 141: 79–87
   PubMed Web of Science ®Google Scholar
• Group A-REDSR. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 2000; 107: 2224–32
   PubMed Web of Science ®Google Scholar
• McCarty C A, Mukesh B N, Fu C L, Mitchell P, Wang J J, Taylor H R. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol 2001; 119: 1455–62
   PubMed Web of Science ®Google Scholar
• Cruickshanks K J, Klein R, Klein B E, Nondahl D M. Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study. Arch Ophthalmol 2001; 119: 246–50
   PubMedGoogle Scholar
• West S K, Rosenthal F S, Bressler N M, et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 1989; 107: 875–9
   PubMed Web of Science ®Google Scholar
• Taylor H R. Ultraviolet radiation and the eye: an epidemiologic study. Trans Am Ophthalmol Soc 1989; 87: 802–53
   PubMedGoogle Scholar
• Delacourt C, Carriere I, Ponton-Sanchez A, Fourrey S, Lacroux A, Papoz L. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liees a l'Age (POLA) study. Arch Ophthalmol 2001; 119: 1463–8
   Google Scholar
• Miyazaki M, Nakamura H, Kubo M, et al. Risk factors for age related maculopathy in a Japanese population: the Hisayama study. Br J Ophthalmol 2003; 87: 469–72
   PubMedGoogle Scholar
• Klein R, Klein B E, Tomany S C, Cruickshanks K J. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. Ophthalmology 2003; 110: 636–43
   PubMed Web of Science ®Google Scholar
• Smith W, Mitchell P, Leeder S R, Wang J J. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 1998; 116: 583–7
   PubMed Web of Science ®Google Scholar
• Seddon J M, Gensler G, Milton R C, Klein M L, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004; 291: 704–10
   PubMed Web of Science ®Google Scholar
• Seddon J M, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 2003; 121: 785–92
   PubMed Web of Science ®Google Scholar
• Seddon J M, George S, Rosner B, Klein M L. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered 2006; 61: 157–65
   PubMed Web of Science ®Google Scholar
• Xu L, Li Y, Zheng Y, Jonas J B. Associated factors for age related maculopathy in the adult population in China: the Beijing eye study. Br J Ophthalmol 2006; 90: 1087–90
   Google Scholar
• Nicolas C M, Robman L D, Tikellis G, et al. Iris colour, ethnic origin and progression of age-related macular degeneration. Clin Experiment Ophthalmol 2003; 31: 465–9
   Google Scholar
• Mitchell P, Smith W, Wang J J. Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study. Ophthalmology 1998; 105: 1359–63
   PubMed Web of Science ®Google Scholar
• Tomany S C, Klein R, Klein B E. The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 2003; 110: 1526–33
   PubMed Web of Science ®Google Scholar
• Wang J J, Jakobsen K, Smith W, Mitchell P. Five-year incidence of age-related maculopathy in relation to iris, skin or hair colour, and skin sun sensitivity: the Blue Mountains Eye Study. Clin Experiment Ophthalmol 2003; 31: 317–21
   PubMedGoogle Scholar
• Buch H, Vinding T, la Cour M, Jensen G B, Prause J U, Nielsen N V. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmol Scand 2005; 83: 409–18
   PubMedGoogle Scholar
• de Lorimier A A. Alcohol, wine, and health. Am J Surg 2000; 180: 357–61
   PubMed Web of Science ®Google Scholar
• Cho E, Hankinson S E, Willett W C, et al. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch Ophthalmol 2000; 118: 681–8
   PubMed Web of Science ®Google Scholar
• Cho E, Hung S, Willett W C, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001; 73: 209–18
   PubMed Web of Science ®Google Scholar
• Seddon J M, Rosner B, Sperduto R D, et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 2001; 119: 1191–9
   PubMed Web of Science ®Google Scholar
• Seddon J M, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol 2003; 121: 1728–37
   PubMed Web of Science ®Google Scholar
• Seddon J M, Ajani U A, Sperduto R D, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994; 272: 1413–20
   PubMed Web of Science ®Google Scholar
• Guymer R H, Chong E W. Modifiable risk factors for age-related macular degeneration. Med J Aust 2006; 184: 455–8
   PubMed Web of Science ®Google Scholar
• Newsome D A, Swartz M, Leone N C, Elston R C, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol 1988; 106: 192–8
   PubMed Web of Science ®Google Scholar
• Mares J A. Potential value of antioxidant-rich foods in slowing age-related macular degeneration. Arch Ophthalmol 2006; 124: 1339–40
   Google Scholar
• Cho E, Seddon J M, Rosner B, Willett W C, Hankinson S E. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol 2004; 122: 883–92
   PubMed Web of Science ®Google Scholar
• Seddon J M, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol 2006; 124: 995–1001
   PubMed Web of Science ®Google Scholar
• Chua B, Flood V, Rochtchina E, Wang J J, Smith W, Mitchell P. Dietary fatty acids and the 5-year incidence of age-related maculopathy. Arch Ophthalmol 2006; 124: 981–6
   PubMedGoogle Scholar
• Zarbin M A. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004; 122: 598–614
   PubMed Web of Science ®Google Scholar
• Nilsson S E. From basic to clinical research: a journey with the retina, the retinal pigment epithelium, the cornea, age-related macular degeneration and hereditary degenerations, as seen in the rear view mirror. Acta Ophthalmol Scand 2006; 84: 452–65
   Google Scholar
• Wihlmark U, Wrigstad A, Roberg K, Brunk U T, Nilsson S E. Lipofuscin formation in cultured retinal pigment epithelial cells exposed to photoreceptor outer segment material under different oxygen concentrations. APMIS 1996; 104: 265–71
   Google Scholar
• Nilsson S E, Sundelin S P, Wihlmark U, Brunk U T. Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage. Doc Ophthalmol 2003; 106: 13–6
   PubMed Web of Science ®Google Scholar
• Sundelin S P, Nilsson S E. Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants. Free Radic Biol Med 2001; 31: 217–25
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119: 1417–36
   PubMed Web of Science ®Google Scholar
• Imamura Y, Noda S, Hashizume K, et al. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A 2006; 103: 11282–7
   PubMed Web of Science ®Google Scholar
• Patel N, Ohbayashi M, Nugent A K, et al. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 2005; 115: 422–30
   PubMedGoogle Scholar
• Hageman G S, Mullins R F, Russell S R, Johnson L V, Anderson D H. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. Faseb J 1999; 13: 477–84
   PubMed Web of Science ®Google Scholar
• Hageman G S, Luthert P J, Victor Chong N H, Johnson L V, Anderson D H, Mullins R F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001; 20: 705–32
   PubMed Web of Science ®Google Scholar
• Mullins R F, Russell S R, Anderson D H, Hageman G S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. Faseb J 2000; 14: 835–46
   PubMed Web of Science ®Google Scholar
• Killingsworth M C, Sarks J P, Sarks S H. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 1990; 4: 613–21, (Pt 4)
   PubMed Web of Science ®Google Scholar
• Anderson D H, Mullins R F, Hageman G S, Johnson L V. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002; 134: 411–31
   PubMed Web of Science ®Google Scholar
• Penfold P L, Madigan M C, Gillies M C, Provis J M. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 2001; 20: 385–414
   PubMed Web of Science ®Google Scholar
• Penfold P L, Liew S C, Madigan M C, Provis J M. Modulation of major histocompatibility complex class II expression in retinas with age-related macular degeneration. Invest Ophthalmol Vis Sci 1997; 38: 2125–33
   PubMed Web of Science ®Google Scholar
• Goverdhan S V, Howell M W, Mullins R F, et al. Association of HLA class I and class II polymorphisms with age-related macular degeneration. Invest Ophthalmol Vis Sci 2005; 46: 1726–34
   PubMedGoogle Scholar
• Haines J L, Hauser M A, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308: 419–21
   PubMed Web of Science ®Google Scholar
• Edwards A O, Ritter R, 3rd, Abel K J, Manning A, Panhuysen C, Farrer L A. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421–4
   PubMed Web of Science ®Google Scholar
• Klein R J, Zeiss C, Chew E Y, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385–9
   PubMed Web of Science ®Google Scholar
• Gold B, Merriam J E, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006; 38: 458–62
   PubMed Web of Science ®Google Scholar
• Maller J, George S, Purcell S, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006; 38: 1055–9
   PubMed Web of Science ®Google Scholar
• Klein M L, Mauldin W M, Stoumbos V D. Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch Ophthalmol 1994; 112: 932–7
   PubMedGoogle Scholar
• Meyers S M, Greene T, Gutman F A. A twin study of age-related macular degeneration. Am J Ophthalmol 1995; 120: 757–66
   PubMed Web of Science ®Google Scholar
• Gottfredsdottir M S, Sverrisson T, Musch D C, Stefansson E. Age related macular degeneration in monozygotic twins and their spouses in Iceland. Acta Ophthalmol Scand 1999; 77: 422–5
   PubMedGoogle Scholar
• Seddon J M, Cote J, Page W F, Aggen S H, Neale M C. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 2005; 123: 321–7
   PubMed Web of Science ®Google Scholar
• Seddon J M, Ajani U A, Mitchell B D. Familial aggregation of age-related maculopathy. Am J Ophthalmol 1997; 123: 199–206
   PubMed Web of Science ®Google Scholar
• Hyman L G, Lilienfeld A M, Ferris F L, 3rd, Fine S L. Senile macular degeneration: a case-control study. Am J Epidemiol 1983; 118: 213–27
   PubMed Web of Science ®Google Scholar
• Silvestri G, Johnston P B, Hughes A E. Is genetic predisposition an important risk factor in age-related macular degeneration?. Eye 1994; 8: 564–8, (Pt 5)
   PubMed Web of Science ®Google Scholar
• Klaver C C, Wolfs R C, Assink J J, van Duijn C M, Hofman A, de Jong P T. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 1998; 116: 1646–51
   PubMedGoogle Scholar
• Klein B E, Klein R, Lee K E, Moore E L, Danforth L. Risk of incident age-related eye diseases in people with an affected sibling: The Beaver Dam Eye Study. Am J Epidemiol 2001; 154: 207–11
   PubMedGoogle Scholar
• Klein M L, Schultz D W, Edwards A, et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol 1998; 116: 1082–8
   PubMed Web of Science ®Google Scholar
• Seddon J M, Santangelo S L, Book K, Chong S, Cote J. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 2003; 73: 780–90
   PubMed Web of Science ®Google Scholar
• Abecasis G R, Yashar B M, Zhao Y, et al. Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet 2004; 74: 482–94
   PubMed Web of Science ®Google Scholar
• Iyengar S K, Song D, Klein B E, et al. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet 2004; 74: 20–39
   PubMed Web of Science ®Google Scholar
• Majewski J, Schultz D W, Weleber R G, et al. Age-related macular degeneration–a genome scan in extended families. Am J Hum Genet 2003; 73: 540–50
   PubMed Web of Science ®Google Scholar
• Schultz D W, Klein M L, Humpert A J, et al. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet 2003; 12: 3315–23
   PubMed Web of Science ®Google Scholar
• Hayashi M, Merriam J E, Klaver C C, et al. Evaluation of the ARMD1 locus on 1q25-31 in patients with age-related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN-1. Ophthalmic Genet 2004; 25: 111–9
   PubMedGoogle Scholar
• Stone E M, Braun T A, Russell S R, et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med 2004; 351: 346–53
   PubMed Web of Science ®Google Scholar
• Marmorstein L. Association of EFEMP1 with malattia leventinese and age-related macular degeneration: a mini-review. Ophthalmic Genet 2004; 25: 219–26
   Google Scholar
• Weeks D E, Conley Y P, Tsai H J, et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet 2004; 75: 174–89
   PubMed Web of Science ®Google Scholar
• Fisher S A, Abecasis G R, Yashar B M, et al. Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet 2005; 14: 2257–64
   PubMed Web of Science ®Google Scholar
• Rivera A, Fisher S A, Fritsche L G, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005; 14: 3227–36
   PubMed Web of Science ®Google Scholar
• Jakobsdottir J, Conley Y P, Weeks D E, Mah T S, Ferrell R E, Gorin M B. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005; 77: 389–407
   PubMed Web of Science ®Google Scholar
• Haddad S, Chen C A, Santangelo S L, Seddon J M. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol 2006; 51: 316–63
   PubMed Web of Science ®Google Scholar
• Allikmets R. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 1997; 17: 122
   PubMed Web of Science ®Google Scholar
• Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 2000; 67: 487–91
   PubMed Web of Science ®Google Scholar
• Allikmets R, Shroyer N F, Singh N, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997; 277: 1805–7
   PubMed Web of Science ®Google Scholar
• Zhang K, Kniazeva M, Hutchinson A, Han M, Dean M, Allikmets R. The ABCR gene in recessive and dominant Stargardt diseases: a genetic pathway in macular degeneration. Genomics 1999; 60: 234–7
   Google Scholar
• Souied E H, Ducroq D, Rozet J M, et al. ABCR gene analysis in familial exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 2000; 41: 244–7
   Google Scholar
• Shroyer N F, Lewis R A, Yatsenko A N, Wensel T G, Lupski J R. Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration. Hum Mol Genet 2001; 10: 2671–8
   Google Scholar
• Rivera A, White K, Stohr H, et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet 2000; 67: 800–13
   PubMed Web of Science ®Google Scholar
• Kuroiwa S, Kojima H, Kikuchi T, Yoshimura N. ATP binding cassette transporter retina genotypes and age related macular degeneration: an analysis on exudative non-familial Japanese patients. Br J Ophthalmol 1999; 83: 613–5
   PubMedGoogle Scholar
• Fuse N, Suzuki T, Wada Y, et al. Molecular genetic analysis of ABCR gene in Japanese dry form age-related macular degeneration. Jpn J Ophthalmol 2000; 44: 245–9
   Google Scholar
• Guymer R H, Heon E, Lotery A J, et al. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol 2001; 119: 745–51
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Chong N V. The complement system and age-related macular degeneration. Eye 2006; 20: 867–72
   PubMed Web of Science ®Google Scholar
• Blackmore T K, Sadlon T A, Ward H M, Lublin D M, Gordon D L. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. J Immunol 1996; 157: 5422–7
   PubMed Web of Science ®Google Scholar
• Blackmore T K, Fischetti V A, Sadlon T A, Ward H M, Gordon D L. M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H. Infect Immun 1998; 66: 1427–31
   PubMed Web of Science ®Google Scholar
• Blackmore T K, Hellwage J, Sadlon T A, et al. Identification of the second heparin-binding domain in human complement factor H. J Immunol 1998; 160: 3342–8
   PubMed Web of Science ®Google Scholar
• Giannakis E, Jokiranta T S, Male D A, et al. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. Eur J Immunol 2003; 33: 962–9
   Google Scholar
• Despriet D D, Klaver C C, Witteman J C, et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006; 296: 301–9
   PubMed Web of Science ®Google Scholar
• Hageman G S, Anderson D H, Johnson L V, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 2005; 102: 7227–32
   PubMed Web of Science ®Google Scholar
• Zareparsi S, Branham K E, Li M, et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 2005; 77: 149–53
   PubMed Web of Science ®Google Scholar
• Baird P N, Islam F M, Richardson A J, Cain M, Hunt N, Guymer R. Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration. Invest Ophthalmol Vis Sci 2006; 47: 4194–8
   PubMed Web of Science ®Google Scholar
• Thakkinstian A, Han P, McEvoy M, et al. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 2006; 15: 2784–90
   PubMed Web of Science ®Google Scholar
• Schmidt S, Hauser M A, Scott W K, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006; 78: 852–64
   PubMed Web of Science ®Google Scholar
• Deangelis M M, Ji F, Kim I K, et al. Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. Arch Ophthalmol 2007; 125: 49–54
   PubMedGoogle Scholar
• Souied E H, Leveziel N, Richard F, et al. Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol Vis 2005; 11: 1135–40
   PubMed Web of Science ®Google Scholar
• Simonelli F, Frisso G, Testa F, et al. Polymorphism p.402Y > H in the complement factor H protein is a risk factor for age related macular degeneration in an Italian population. Br J Ophthalmol 2006; 90: 1142–5
   PubMed Web of Science ®Google Scholar
• Fisher S A, Rivera A, Fritsche L G, Babadjanova G, Petrov S, Weber B H. Assessment of the contribution of CFH and chromosome 10q26 AMD susceptibility loci in a Russian population isolate. Br J Ophthalmol 2006
   Google Scholar
• Kaur I, Hussain A, Hussain N, et al. Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration. Invest Ophthalmol Vis Sci 2006; 47: 3729–35
   PubMed Web of Science ®Google Scholar
• Sepp T, Khan J C, Thurlby D A, et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci 2006; 47: 536–40
   PubMed Web of Science ®Google Scholar
• Seitsonen S, Lemmela S, Holopainen J, et al. Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population. Mol Vis 2006; 12: 796–801
   PubMed Web of Science ®Google Scholar
• Lau L I, Chen S J, Cheng C Y, et al. Association of the Y402H polymorphism in complement factor H gene and neovascular age–related macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci 2006; 47: 3242–6
   PubMed Web of Science ®Google Scholar
• Uka J, Tamura H, Kobayashi T, et al. No association of complement factor H gene polymorphism and age-related macular degeneration in the Japanese population. Retina 2006; 26: 985–7
   PubMedGoogle Scholar
• Tedeschi-Blok N, Buckley J, Varma R, Triche T J, Hinton D R. Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease. Ophthalmology 2007; 114: 99–103
   Google Scholar
• Li M, Atmaca-Sonmez P, Othman M, et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 2006; 38: 1049–54
   PubMed Web of Science ®Google Scholar
• Hughes A E, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 2006; 38: 1173–7
   PubMed Web of Science ®Google Scholar
• Chan C C, Tuo J, Bojanowski C M, Csaky K G, Green W R. Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration. Histol Histopathol 2005; 20: 857–63
   PubMed Web of Science ®Google Scholar
• Tuo J, Smith B C, Bojanowski C M, et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. Faseb J 2004; 18: 1297–9
   PubMed Web of Science ®Google Scholar
• Haines J L, Schnetz-Boutaud N, Schmidt S, et al. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci 2006; 47: 329–35
   PubMed Web of Science ®Google Scholar
• Ayyagari R, Zhang K, Hutchinson A, et al. Evaluation of the ELOVL4 gene in patients with age-related macular degeneration. Ophthalmic Genet 2001; 22: 233–9
   PubMedGoogle Scholar
• Conley Y P, Thalamuthu A, Jakobsdottir J, et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genet 2005; 14: 1991–2002
   PubMed Web of Science ®Google Scholar
• Conley Y P, Jakobsdottir J, Mah T, et al. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet 2006; 15: 3206–18
   PubMed Web of Science ®Google Scholar
• Yang Z, Camp N J, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006; 314: 992–3
   PubMed Web of Science ®Google Scholar
• Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006; 314: 989–92
   PubMed Web of Science ®Google Scholar
• Schaumberg D A, Hankinson S E, Guo Q, Rimm E, Hunter D J. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 2007; 125: 55–62
   PubMed Web of Science ®Google Scholar
• Francis P J, George S, Schultz D W, et al. The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered 2007; 63: 212–218
   PubMedGoogle Scholar
• Seddon J M, Francis P J, George S, Schultz D W, Rosner B, Klein M L. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 2007; 297: 1793–800
   PubMed Web of Science ®Google Scholar
• Mullins R F, Olvera M A, Clark A F, Stone E M. Fibulin-5 distribution in human eyes: Relevance to age-related macular degeneration. Exp Eye Res 2007; 84: 378–80
   Google Scholar
• Lotery A J, Baas D, Ridley C, et al. Reduced secretion of fibulin 5 in age-related macular degeneration and cutis laxa. Hum Mutat 2006; 27: 568–74
   PubMed Web of Science ®Google Scholar
• Bojanowski C M, Shen D, Chew E Y, et al. An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation. Environ Mol Mutagen 2006; 47: 594–602
   PubMed Web of Science ®Google Scholar
• Baird P N, Richardson A J, Robman L D, et al. Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD). Hum Mutat 2006; 27: 337–42
   PubMed Web of Science ®Google Scholar
• Schultz D W, Klein M L, Humpert A, et al. Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch Ophthalmol 2003; 121: 679–83
   PubMedGoogle Scholar
• Gotoh N, Kuroiwa S, Kikuchi T, et al. Apolipoprotein E polymorphisms in Japanese patients with polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Am J Ophthalmol 2004; 138: 567–73
   PubMed Web of Science ®Google Scholar
• Zareparsi S, Reddick A C, Branham K E, et al. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci 2004; 45: 1306–10
   PubMed Web of Science ®Google Scholar
• Schmidt S, Haines J L, Postel E A, et al. Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Mol Vis 2005; 11: 941–9
   PubMed Web of Science ®Google Scholar
• Seddon J M, De La Paz M, Clements K, Pericak-Vance M, Haines J. No association between apolipoprotein E and advanced age-related macular degeneration. Am J Hum Gen 1996; 59: A388
   Google Scholar
• Maller J B, Fagerness J A, Reynolds R C, Neale B M, Daly M J, Seddon J M. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Gen 2007; 39: 1200–1201
   PubMed Web of Science ®Google Scholar
• Yeates J RW, Sepp T, Matharu B H, et al. Complement C3 variant and the risk of age-related macular degeneration. NEJM 2007; 357: 553–61
   Google Scholar
• Yuzawa M, Tamakoshi A, Kawamura T, Ohno Y, Uyama M, Honda T. Report on the nationwide epidemiological survey of exudative age-related macular degeneration in Japan. Int Ophthalmol 1997; 21: 1–3
   PubMedGoogle Scholar
• Maruo T, Ikebukuro N, Kawanabe K, Kubota N. Changes in causes of visual handicaps in Tokyo. Jpn J Ophthalmol 1991; 35: 268–72
   PubMedGoogle Scholar
• Yates J R, Moore A T. Genetic susceptibility to age related macular degeneration. J Med Genet 2000; 37: 83–7
   PubMed Web of Science ®Google Scholar